The sustainability of weight-loss drugs is under scrutiny as new research shows that people who stop taking glucagon-like ...

Research is exposing the limitations of weight loss drugs but grandmother Karen Holman is determined to stay slimmer.

Studying wild rock doves gives us a rare chance to establish how one of science’s model species lives in nature. This may yield insights into domestication, wild-feral hybridisation, and ...

California healthcare innovator Amgen, which already has facilities at Cambridge Science Park, has made a new and incisive acquisition in the UK - buying Oxford University spin-out Dark Blue ...

As technological risk increasingly becomes a global consensus, Chinese scholar Hu Jiaqi and the relevant research teams at Oxford University have each constructed significant intellectual frameworks ...

In summer 2026, scientists at the University of Oxford and University College London plan to begin a first-of-its-kind ...

Encouraged by these results, Dudin, Dey, Guichard, and Hamel launched a close collaboration. Three years later, their work has produced near-encyclopedic insight into hundreds of protist species and ...

Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its CEO & President, Najat Khan, Ph.D., will present Tuesday, January 13 ...

Amgen is adding Dark Blue to its tapestry, embedding the U.K. biotech’s preclinical blood cancer program into its ...

OXFORD, England, Jan. 6, 2026 /PRNewswire/ -- Dark Blue Therapeutics ("Dark Blue"), a discovery and development biotech company pioneering the next generation of precision oncology medicines, has been ...

The article 🌱 Patch AM: How a Herndon native’s leap of faith led to Oxford appeared first on Herndon Patch. Good morning Herndon! We're back in your inbox this morning to keep you in the loop with ...